patent-landscape

name	patent-landscape
description	Analyze patent landscapes for biopharma assets, targets, and therapeutic areas. Covers prior art, freedom-to-operate, patent expiry, IP positioning, and competitive IP mapping. Use when users ask about patents, IP landscape, freedom to operate, patent cliffs, or exclusivity.
user-invocable	false

Patent Landscape Analysis

Analyze intellectual property landscapes for biopharma due diligence and competitive intelligence.

Data Sources

Gosset MCP Tools

• find_drugs — Get drug details including developers and modalities
• find_deals — Licensing deals often reflect IP value
• find_companies — Company IP portfolios
• gosset_agent — Deep research on IP strategy and patent details

Web Search (Primary for patent data)

• Google Patents for patent search and full-text access
• USPTO, EPO, WIPO for official filings
• Orange Book (FDA) for listed patents and exclusivities
• Purple Book for biosimilar reference products
• Patent expiry databases

When to Use

• Due diligence on a drug asset's IP position
• Freedom-to-operate analysis for a new program
• Patent cliff analysis and generic/biosimilar entry timing
• Competitive IP mapping in a therapeutic area
• Licensing deal IP assessment

Workflow

Step 1: Define Scope

• Asset-specific: Patents protecting a specific drug
• Target-specific: Patent landscape around a molecular target
• Indication-specific: IP landscape in a therapeutic area
• Technology-specific: Platform/modality patent landscape

Step 2: Gather Patent Data

Asset IP Profile:

# Get drug details and developer
find_drugs(query="[drug name]", limit=5, effort="high")

# Research patent portfolio
gosset_agent(prompt="What are the key patents protecting [drug name]? Include composition of matter, formulation, method of use, and process patents. What are the expiry dates?")

Competitive IP Mapping:

# Find all drugs in the space
find_drugs(query="[target/indication]", limit=50, effort="high")

# Research IP landscape
gosset_agent(prompt="Map the patent landscape for [target] inhibitors. Who holds key composition of matter patents? What are the blocking patents?")

Step 3: Analysis

Patent Categories to Track:

Category	Description	Impact
Composition of matter	Core compound patents	Strongest protection
Formulation	Drug product patents	Extends lifecycle
Method of use	Indication-specific patents	Label protection
Process/manufacturing	Synthesis patents	Supply chain barrier
Combination	Fixed-dose combinations	Portfolio extension
Polymorph/salt	Crystal form patents	Lifecycle management

Key Dates:

• Patent filing and grant dates
• Patent expiry dates (including PTEs, SPCs)
• Regulatory exclusivity expiry (NCE, orphan, pediatric)
• First possible generic/biosimilar entry
• Paragraph IV certification deadlines

Step 4: Report

1. Executive Summary — Key IP risks and opportunities
2. Patent Portfolio Map — Table of patents by category, dates, status
3. Freedom to Operate — Blocking patents, design-around options
4. Patent Cliff Timeline — Expiry dates and exclusivity loss schedule
5. Competitive IP Positioning — Who holds what, white space
6. Recommendations — IP strategy implications for the deal/program